Xiaflex was approved in 2010 for the treatment of Dupuytren’s contracture. Dupuytren’s contracture is a condition where nodules form under the skin in the palm of the hand. These nodules thicken and ...

This is the first part of a three-part interview from Broncos Wire's Brandon Walker with Pro Football Hall of Fame quarterback John Elway. This first story focuses on Elway's diagnosis of Dupuytren's ...

This week, we are going to discuss a hand condition that is quite problematic and can be very limiting for patients suffering from this condition – Dupuytren’s contracture. Dupuytren’s contracture is ...

If you have Dupuytren’s contracture or Peyronie’s disease, your doctor may suggest treatment with Xiaflex. This is a prescription medication used to treat these two conditions in adults in certain ...

DUBLIN--(BUSINESS WIRE)--The "Dupuytren's Disease Market Size, Share & Trends Analysis Report By Type (Diagnosis, Treatment), By Disease Type (Type I, Type II), By End-use (Hospitals, Clinics), By ...

Treatments for Dupuytren’s contracture include limited fasciectomy and collagenase injection. Comparisons of the effectiveness of these treatments have been limited. We performed an unblinded, ...

In a series of unscripted videos, known as Coffee & Cords, patients share details about living with Dupuytren's contracture, a progressive hand condition that forms a collagen rope-like cord that ...

If you have Dupuytren's contracture, you're likely familiar with the many nonsurgical ways to manage the condition, including hand exercises, physical therapy, and injections. While these treatments ...

Pro Football Hall of Famer John Elway is once again teaming up with Endo to raise awareness about Dupuytren’s contracture. Endo reupped with the Super Bowl-winning quarterback of the Denver Broncos ...

(MENAFN- EIN Presswire) EINPresswire/ -- Dupuytren's UK, led by renowned consultant radiotherapy specialist Dr Richard Shaffer, has launched an awareness campaign spotlighting low-dose radiotherapy as ...

PALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company and its regulatory consultants from the US ...